Exploring the modulatory impact of isosakuranetin on Staphylococcus aureus: Inhibition of sortase A activity and α-haemolysin expression

References

• Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol. 2010;64:143–16. doi: 10.1146/annurev.micro.112408.134309
   PubMed Web of Science ®Google Scholar
• Lindsay JA. Evolution of Staphylococcus aureus and MRSA during outbreaks. Infect Genet Evol. 2014;21:548–553. doi: 10.1016/j.meegid.2013.04.017
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao J, Barkema HW, et al. Virulence gene profiles: alpha-hemolysin and clonal diversity in Staphylococcus aureus isolates from bovine clinical mastitis in China. BMC Vet Res. 2018;14(1):63. doi: 10.1186/s12917-018-1374-7
   PubMedGoogle Scholar
• Venter H. Reversing resistance to counter antimicrobial resistance in the World Health Organisation’s critical priority of most dangerous pathogens. Biosci Rep. 2019;39(4). doi: 10.1042/bsr20180474
   PubMedGoogle Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi: 10.1016/s1473-3099(13)70318-9
   PubMed Web of Science ®Google Scholar
• Medina E, Pieper DH. Tackling threats and future problems of multidrug-resistant bacteria. Curr Top Microbiol Immunol. 2016;398:3–33. doi: 10.1007/82_2016_492
   PubMed Web of Science ®Google Scholar
• Beltran JA, Del Rio G, Brizuela CA. An automatic representation of peptides for effective antimicrobial activity classification. Comput Struct Biotechnol J. 2020;18:455–463. doi: 10.1016/j.csbj.2020.02.002
   PubMed Web of Science ®Google Scholar
• Chawla M, Verma J, Gupta R, et al. Antibiotic potentiators against Multidrug-Resistant Bacteria: discovery, development, and clinical relevance. Front Microbiol. 2022;13:887251. doi: 10.3389/fmicb.2022.887251
   PubMed Web of Science ®Google Scholar
• Wang CH, Hsieh YH, Powers ZM, et al. Defeating antibiotic-resistant bacteria: exploring alternative therapies for a post-antibiotic era. Int J Mol Sci. 2020;21(3). doi: 10.3390/ijms21031061
   Web of Science ®Google Scholar
• Kirienko NV, Rahme L, Cho YH. Editorial: beyond antimicrobials: non-traditional approaches to combating multidrug-resistant bacteria. Front Cell Infect Microbiol. 2019;9:343. doi: 10.3389/fcimb.2019.00343
   PubMed Web of Science ®Google Scholar
• Mühlen S, Dersch P. Anti-virulence strategies to target bacterial infections. Curr Top Microbiol Immunol. 2016;398:147–183. doi: 10.1007/82_2015_490
   PubMed Web of Science ®Google Scholar
• Zucca M, Savoia D. The post-antibiotic era: promising developments in the therapy of infectious diseases. Int J Biomed Sci. 2010;6(2):77–86.
   PubMedGoogle Scholar
• Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547–569. doi: 10.1080/21505594.2021.1878688
   PubMed Web of Science ®Google Scholar
• Si L, Li P, Liu X, et al. Chinese herb medicine against sortase a catalyzed transformations, a key role in gram-positive bacterial infection progress. J Enzyme Inhib Med Chem. 2016;31(sup1):184–196. doi: 10.1080/14756366.2016.1178639
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Zhu K, et al. Antiinfective therapy with a small molecule inhibitor of Staphylococcus aureus sortase. Proc Natl Acad Sci U S A. 2014;111(37):13517–13522. doi: 10.1073/pnas.1408601111
   PubMed Web of Science ®Google Scholar
• Alharthi S, Alavi SE, Moyle PM, et al. Sortase a (SrtA) inhibitors as an alternative treatment for superbug infections. Drug Discov Today. 2021;26(9):2164–2172. doi: 10.1016/j.drudis.2021.03.019
   PubMed Web of Science ®Google Scholar
• Cascioferro S, Totsika M, Schillaci D. Sortase A: an ideal target for anti-virulence drug development. Microb Pathog. 2014;77:105–112. doi: 10.1016/j.micpath.2014.10.007
   PubMed Web of Science ®Google Scholar
• Hussain M, Kohler C, Becker K. Role of SrtA in pathogenicity of Staphylococcus lugdunensis. Microorganisms. 2020;8(12). doi: 10.3390/microorganisms8121975
   Web of Science ®Google Scholar
• Mazmanian SK, Ton-That H, Schneewind O. Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus. Mol Microbiol. 2001;40(5):1049–1057. doi: 10.1046/j.1365-2958.2001.02411.x
   PubMed Web of Science ®Google Scholar
• Mazmanian SK, Liu G, Jensen ER, et al. Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc Natl Acad Sci U S A. 2000;97(10):5510–5515. doi: 10.1073/pnas.080520697
   PubMed Web of Science ®Google Scholar
• Weiss WJ, Lenoy E, Murphy T, et al. Effect of srtA and srtB gene expression on the virulence of Staphylococcus aureus in animal models of infection. J Antimicrob Chemother. 2004;53(3):480–486. doi: 10.1093/jac/dkh078
   PubMed Web of Science ®Google Scholar
• Maresso AW, Schneewind O. Sortase as a target of anti-infective therapy. Pharmacol Rev. 2008;60(1):128–141. doi: 10.1124/pr.107.07110
   PubMed Web of Science ®Google Scholar
• Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991;55(4):733–751. doi: 10.1128/mr.55.4.733-751.1991
   PubMedGoogle Scholar
• Valeva A, Walev I, Pinkernell M, et al. Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A. 1997;94(21):11607–11611. doi: 10.1073/pnas.94.21.11607
   PubMed Web of Science ®Google Scholar
• Kennedy AD, Bubeck Wardenburg J, Gardner DJ, et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis. 2010;202(7):1050–1058. doi: 10.1086/656043
   PubMed Web of Science ®Google Scholar
• Krüll M, Dold C, Hippenstiel S, et al. Escherichia coli hemolysin and Staphylococcus aureus alpha-toxin potently induce neutrophil adhesion to cultured human endothelial cells. J Immunol. 1996;157(9):4133–4140. doi: 10.4049/jimmunol.157.9.4133
   PubMed Web of Science ®Google Scholar
• Liang X, Ji Y. Alpha-toxin interferes with integrin-mediated adhesion and internalization of Staphylococcus aureus by epithelial cells. Cell Microbiol. 2006;8(10):1656–1668. doi: 10.1111/j.1462-5822.2006.00740.x
   PubMed Web of Science ®Google Scholar
• Berube BJ, Bubeck Wardenburg J. Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel). 2013;5(6):1140–1166. doi: 10.3390/toxins5061140
   PubMed Web of Science ®Google Scholar
• Virreira Winter S, Zychlinsky A, Bardoel BW. Genome-wide CRISPR screen reveals novel host factors required for Staphylococcus aureus α-hemolysin-mediated toxicity. Sci Rep. 2016;6:24242. doi: 10.1038/srep24242
   PubMed Web of Science ®Google Scholar
• Nygaard TK, Pallister KB, DuMont AL, et al. Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection. PLoS One. 2012;7(5):e36532. doi: 10.1371/journal.pone.0036532
   PubMed Web of Science ®Google Scholar
• Drira R, Sakamoto K. Isosakuranetin, a 4’-O-methylated flavonoid, stimulates melanogenesis in B16BL6 murine melanoma cells. Life Sci. 2015;143:43–49. doi: 10.1016/j.lfs.2015.10.009
   PubMed Web of Science ®Google Scholar
• Jia S, Zhang Y, Yu J. Antinociceptive effects of isosakuranetin in a rat model of peripheral neuropathy. Pharmacology. 2017;100(3–4):201–207. doi: 10.1159/000478986
   PubMed Web of Science ®Google Scholar
• Wang L, Li Q, Li J, et al. Eriodictyol as a potential candidate inhibitor of sortase a protects mice from methicillin-resistant Staphylococcus aureus-induced pneumonia. Front Microbiol. 2021b;12:635710. doi: 10.3389/fmicb.2021.635710
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31(2):NA–NA. doi: 10.1002/jcc.21334
   Web of Science ®Google Scholar
• Wang L, Jing S, Qu H, et al. Orientin mediates protection against MRSA-induced pneumonia by inhibiting sortase a. Virulence. 2021a;12(1):2149–2161. doi: 10.1080/21505594.2021.1962138
   PubMed Web of Science ®Google Scholar
• Song W, Wang L, Jin M, et al. Punicalagin, an inhibitor of sortase A, is a promising therapeutic drug to combat methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother. 2022;66(6):e0022422. doi: 10.1128/aac.00224-22
   PubMed Web of Science ®Google Scholar
• Hou X, Wang M, Wen Y, et al. Quinone skeleton as a new class of irreversible inhibitors against Staphylococcus aureus sortase a. Bioorg Med Chem Lett. 2018;28(10):1864–1869. doi: 10.1016/j.bmcl.2018.04.005
   PubMed Web of Science ®Google Scholar
• Falugi F, Kim HK, Missiakas DM, et al. Role of protein a in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio. 2013;4(5):e00575–00513. doi: 10.1128/mBio.00575-13
   PubMed Web of Science ®Google Scholar
• Qin C, Xin X, Pei X, et al. Amorphous Nanosuspensions Aggregated from paclitaxel–hemoglobulin complexes with enhanced cytotoxicity. Pharmaceutics. 2018;10(3):92. doi: 10.3390/pharmaceutics10030092
   PubMed Web of Science ®Google Scholar
• Melander RJ, Zurawski DV, Melander C. Narrow-Spectrum antibacterial Agents. Med Chem Commun. 2018;9(1):12–21. doi: 10.1039/c7md00528h
   Google Scholar
• Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol. 2012;2:12. doi: 10.3389/fcimb.2012.00012
   PubMed Web of Science ®Google Scholar
• Wolfmeier H, Mansour SC, Liu LT, et al. Liposomal therapy attenuates dermonecrosis induced by community-associated methicillin-resistant Staphylococcus aureus by targeting α-type phenol-soluble modulins and α-hemolysin. EBioMedicine. 2018;33:211–217. doi: 10.1016/j.ebiom.2018.06.016
   PubMed Web of Science ®Google Scholar
• Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov. 2010;9(2):117–128. doi: 10.1038/nrd3013
   PubMed Web of Science ®Google Scholar
• Powers ME, Kim HK, Wang Y, et al. ADAM10 mediates vascular injury induced by Staphylococcus aureus α-hemolysin. J Infect Dis. 2012;206(3):352–356. doi: 10.1093/infdis/jis192
   PubMed Web of Science ®Google Scholar
• Wilke GA, Bubeck Wardenburg J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci U S A. 2010;107(30):13473–13478. doi: 10.1073/pnas.1001815107
   PubMed Web of Science ®Google Scholar
• Wei Y, Xiong J, Larson NR, et al. Effect of 2 emulsion-based adjuvants on the structure and thermal stability of Staphylococcus aureus Alpha-Toxin. J Pharm Sci. 2018;107(9):2325–2334. doi: 10.1016/j.xphs.2018.05.019
   PubMed Web of Science ®Google Scholar
• Kruger RG, Otvos B, Frankel BA, et al. Analysis of the substrate specificity of the Staphylococcus aureus sortase transpeptidase SrtA. Biochemistry. 2004;43(6):1541–1551. doi: 10.1021/bi035920j
   PubMed Web of Science ®Google Scholar
• Wang J, Li H, Pan J, et al. Oligopeptide targeting sortase a as potential anti-infective therapy for Staphylococcus aureus. Front Microbiol. 2018;9:245. doi: 10.3389/fmicb.2018.00245
   PubMed Web of Science ®Google Scholar
• Frankel BA, Kruger RG, Robinson DE, et al. Staphylococcus aureus sortase transpeptidase SrtA: insight into the kinetic mechanism and evidence for a reverse protonation catalytic mechanism. Biochemistry. 2005;44(33):11188–11200. doi: 10.1021/bi050141j
   PubMed Web of Science ®Google Scholar
• Frankel BA, Tong Y, Bentley ML, et al. Mutational analysis of active site residues in the Staphylococcus aureus transpeptidase SrtA. Biochemistry. 2007;46(24):7269–7278. doi: 10.1021/bi700448e
   PubMed Web of Science ®Google Scholar
• Huang X, Aulabaugh A, Ding W, et al. Kinetic mechanism of Staphylococcus aureus sortase SrtA. Biochemistry. 2003;42(38):11307–11315. doi: 10.1021/bi034391g
   PubMed Web of Science ®Google Scholar
• Verderosa AD, Dhouib R, Hong Y, et al. A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics. Sci Rep. 2021;11(1):1569. doi: 10.1038/s41598-021-81007-y
   PubMed Web of Science ®Google Scholar